Estate Counselors’s Atea Pharmaceuticals AVIR Stock Holding History

Estate Counselors’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$5K	–	141
2022 Q3	$5K	Sell	1,000 -2,000	-67%	-$15.3K	﹤0.01%	170
2022 Q2	$21K	Hold	3,000	–	–	﹤0.01%	158
2022 Q1	$21K	Buy	+3,000	New	+$20.4K	﹤0.01%	158
2021 Q4	–	Sell	-500	Closed	-$17K	–	167
2021 Q3	$17K	Buy	+500	New	+$13.9K	﹤0.01%	171

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Estate Counselors's AVIR Position: Q4 2022 in Review

Estate Counselors sold out of Atea Pharmaceuticals (AVIR) in Q4 2022, closing a stake of 1,000 shares — an estimated $5K sold.

Estate Counselors first reported a position in AVIR in Q3 2021 and held it in 4 quarters. The position peaked at $21K in Q2 2022. 131 funds tracked by Wall St. Rank hold AVIR as of Q4 2022.

Estate Counselors reported no remaining Atea Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Estate Counselors sold 1,000 Atea Pharmaceuticals shares in Q4 2022, an estimated $5K.
Estate Counselors first reported a position in Atea Pharmaceuticals in Q3 2021 and held it in 4 quarters.
Estate Counselors's Atea Pharmaceuticals position peaked at $21K in Q2 2022.
131 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2022.

Based on Estate Counselors's 13F filing for Q4 2022, filed 8 Feb 2023.